Skip to main content

Table 4 Number of respondents with COPD previously diagnosed and diagnosed by spirometry during the study

From: The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study

 

Ukraine

(n = 939)

Kazakhstan

(n = 945)

Azerbaijan

(n = 933)

Previously diagnosed COPD

N = 10 (1.0%)

N = 13 (1.4%)

N = 4 (0.4%)

Diagnosed by spirometry

N = 30 (3.2%)

N = 63 (6.7%)

N = 35 (3.8%)

Firstly diagnosed by spirometry

N = 27 (2.9%)

N = 58 (6.1%)

N = 33 (3.5%)

COPD severity by GOLD stagea:

 I (Mild)

13 (1.4%)

26 (2.8%)

13 (1.4%)

 II (Moderate)

17 (1.8%)

37 (3.9%)

22 (2.4%)

  1. GOLD Stage I (Mild): FEV1/FVC < 0.70 and FEV1 ≥ 80% predicted
  2. GOLD Stage II (Moderate): FEV1/FVC < 0.70 and 50% ≤ FEV1 < 80% predicted
  3. aThere were no respondents diagnosed with COPD III or IV GOLD stages
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us